PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
Turnover
16.67%
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+11.25%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$126M
AUM Growth
–
Cap. Flow
+$118M
Cap. Flow
% of AUM
93.82%
Top 10 Holdings %
Top 10 Hldgs %
27.06%
Holding
123
New
122
Increased
–
Reduced
–
Closed
–
Avg Time Held
0
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$5.56M |
| 2 |
STJ
St Jude Medical
STJ
|
+$3.47M |
| 3 |
UPI
UROPLASTY INC-NEW
UPI
|
+$3.37M |
| 4 |
Rockwell Medical
RMTI
|
+$3.06M |
| 5 |
HNSN
HANSEN MEDICAL, INC. COM NEW
HNSN
|
+$2.91M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 40.4% |
| 2 | Miscellaneous | 17.49% |
| 3 | Technology | 16.77% |
| 4 | Industrials | 10.26% |
| 5 | Consumer Staples | 4.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CSII
1
DELISTED
Cardiovascular Systems, Inc.
CSII
| $6.07M | 4.82% |
+286,200
| New | +$5.56M |
2013 Q2
0 quarters
|
|
|
STJ
2
DELISTED
St Jude Medical
STJ
| $3.66M | 2.9% |
+80,138
| New | +$3.47M |
2013 Q2
0 quarters
|
|
3
3M
MMM
$84.4B
| $3.58M | 2.85% |
+469
| New | +$42.6K |
2013 Q2
0 quarters
|
|
4
DELISTED
BioTelemetry, Inc.
BEAT
| $3.47M | 2.75% |
+587,818
| New | +$1.98M |
2013 Q2
0 quarters
|
|
|
UPI
5
DELISTED
UROPLASTY INC-NEW
UPI
| $3.05M | 2.42% |
+1,472,321
| New | +$3.37M |
2013 Q2
0 quarters
|
|
|
SPDC
6
DELISTED
SPEED COMMERCE, INC COM STK
SPDC
| $3.05M | 2.42% |
+1,104,000
| New | +$2.72M |
2013 Q2
0 quarters
|
|
|
7
Rockwell Medical
RMTI
$31.6M
| $2.87M | 2.28% |
+7,223
| New | +$3.06M |
2013 Q2
0 quarters
|
|
|
CTG
8
DELISTED
Computer Task Group, Inc.
CTG
| $2.82M | 2.24% |
+122,900
| New | +$2.68M |
2013 Q2
0 quarters
|
|
|
ZIXI
9
DELISTED
Zix Corporation
ZIXI
| $2.77M | 2.19% |
+653,777
| New | +$2.5M |
2013 Q2
0 quarters
|
|
|
HILL
10
DELISTED
DOT HILL SYSTEMS CORP
HILL
| $2.76M | 2.19% |
+1,261,343
| New | +$2.24M |
2013 Q2
0 quarters
|
|
11
Altimmune
ALT
$453M
| $2.53M | 2.01% |
+5,296
| New | +$2.63M |
2013 Q2
0 quarters
|
|
|
HNSN
12
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
| $2.35M | 1.86% |
+163,715
| New | +$2.91M |
2013 Q2
0 quarters
|
|
13
AI Financial Corp
AIFC
$56.5M
| $2.19M | 1.74% |
+170,024
| New | +$1.58M |
2013 Q2
0 quarters
|
|
|
CCIX
14
DELISTED
COLEMAN CABLE IN COM
CCIX
| $2.12M | 1.68% |
+117,350
| New | +$1.98M |
2013 Q2
0 quarters
|
|
|
SAAS
15
DELISTED
inContact, Inc.
SAAS
| $2.05M | 1.62% |
+248,950
| New | +$1.94M |
2013 Q2
0 quarters
|
|
16
ePlus
PLUS
$2.46B
| $2.04M | 1.62% |
+136,000
| New | +$1.68M |
2013 Q2
0 quarters
|
|
17
Pfizer
PFE
$167B
| $2.02M | 1.61% |
+76,179
| New | +$2.1M |
2013 Q2
0 quarters
|
|
|
DTLK
18
DELISTED
Datalink Corp
DTLK
| $2M | 1.59% |
+187,850
| New | +$2.06M |
2013 Q2
0 quarters
|
|
19
LifeVantage
LFVN
$67.6M
| $1.99M | 1.58% |
+122,810
| New | +$1.97M |
2013 Q2
0 quarters
|
|
|
SNAK
20
DELISTED
Inventure Foods, Inc.
SNAK
| $1.95M | 1.55% |
+233,500
| New | +$1.77M |
2013 Q2
0 quarters
|
|
|
SVU
21
DELISTED
SUPERVALU Inc.
SVU
| $1.9M | 1.51% |
+43,564
| New | +$1.83M |
2013 Q2
0 quarters
|
|
22
Cerenome
CNSY
$12.5M
| – | – |
0
| – | – |
2013 Q2
0 quarters
|
|
23
Ionis Pharmaceuticals
IONS
$7.13B
| $1.79M | 1.42% |
+66,750
| New | +$1.42M |
2013 Q2
0 quarters
|
|
|
BAXS
24
DELISTED
BAXANO SURGICAL INC COM STK (DE)
BAXS
| $1.69M | 1.34% |
+702,900
| New | +$1.58M |
2013 Q2
0 quarters
|
|
25
EDAP TMS S.A.
FOCL
$203M
| $1.64M | 1.3% |
+602,850
| New | +$2.15M |
2013 Q2
0 quarters
|
|
Similar funds
AA
WA
AC
BCVI
HAP
RHIG
CWM
SI
Perkins Capital Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Perkins Capital Management, which disclosed 123 positions worth $126M. Its ten largest holdings account for 27% of the portfolio.
Its largest position is Cardiovascular Systems, Inc.: 286,200 shares worth $6.07M.
By sector, the portfolio is most concentrated in Healthcare at 40% of assets, followed by Miscellaneous and Technology.
- Perkins Capital Management's largest Q2 2013 buy was Cardiovascular Systems, Inc.: 286,200 shares worth $6.07M.
- Perkins Capital Management's ten largest holdings make up 27% of its $126M portfolio in Q2 2013.
- Perkins Capital Management disclosed 123 positions in Q2 2013, its first 13F filing on record.
Based on Perkins Capital Management's 13F filing for Q2 2013, filed 15 Aug 2013.